PRESS RELEASE
Pushing mRNA vaccine development timelines to new speeds
February 6, 20256 February 2025; OSLO; PARIS: Scientists in Paris are set to advance new technology that could streamline the production of …
▶
▶
MEDIA COVERAGE
Africa and Europe Join Forces to Revolutionize RNA-based Vaccines and Therapeutics Production: MoU Signed Between EVA Pharma, DNA Script, Quantoom Biosciences
February 5, 2025CAIRO, Egypt – February 5, 2025 – Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have signed a …
▶
▶
MEDIA COVERAGE
DNA Script Breaks Length and Complexity Barriers With New Enzymatic DNA Synthesis Offering
January 30, 2025The new offering delivers exceptional sequence versatility, accommodating challenging compositions including high GC content, poly-A, poly-T, Inverted Terminal Repeat (ITR), …
▶
▶
MEDIA COVERAGE
DNA Script Appoints Marc Montserrat as CEO to Drive Long-Term Commercial Growth for Groundbreaking Enzymatic DNA Synthesis Platform
October 17, 2024Founding CEO Thomas Ybert transitions to Chief Scientific Officer role to underscore company’s ongoing commitment to scientific discovery and innovation PARIS and DALY CITY, Calif. – DNA Script, a leader in enzymatic DNA synthesis, …
▶
▶
PRESS RELEASE
DNA Script to Unveil Industry’s Most Versatile On-site, On-Demand DNA Printer at the World’s Largest Synthetic Biology Conference
May 22, 2023Fully automated SYNTAX platform features latest STX-200 system, enzymatic biochemistry advances, and ready-to-use reagents for producing up to 96 oligos …
▶
▶
MEDIA COVERAGE
DNA Writing Goes Enzymatic, Encourages Pursuit of Bold Visions
December 7, 2022The gold standard for DNA writing, phosphoramidite chemistry, is being challenged by a new method, enzymatic synthesis …
▶
▶
MEDIA COVERAGE
Deeptech Sees Big
November 28, 2022Last October, Bpifrance organized the second edition of Deeptech Sees Big, a highly anticipated event that brought together many students, …
▶
▶
NEWSLETTER
The Transcript, November 2022
November 17, 2022This enewsletter edition highlights our upcoming webinar on accelerated gene fragment assembly EDS, a recent Nature Communication publication by UQ …
▶
▶
PRESS RELEASE
DNA Script Strengthens Its Management Team with the Appointment of Bruno Poddevin as Senior Vice President of Business and Corporate Development
November 9, 2022Poddevin joins DNA Script in a year of immense growth in hiring, financing, commercialization and collaborations. DNA Script, a world …
▶
▶
MEDIA COVERAGE
Biotech Breakthrough 2022 Award Winners
November 3, 2022DNA Script selected as “Overall MedTech Company of the Year” for the Biotech Breakthrough 2022 Awards! …
▶
▶
MEDIA COVERAGE
Europe’s Deeptech ‘Soonicorns’
October 24, 2022(Subscription required) These are the deeptech startups most likely to become unicorns soon. …
▶
▶
MEDIA COVERAGE
Why Good Research Doesn’t Need To Take A Long Time
October 24, 2022Biomedical research takes time—usually not months but, instead, years and sometimes even decades. It’s been programmed into all our expectations …
▶
▶
NEWSLETTER
The Transcript, October 2022
October 20, 2022This enewsletter edition highlights EDS-powered single molecule RNA FISH to enable rapid and cost-effective probe production for smFISH assay development …
▶
▶
MEDIA COVERAGE
The best European startups to work for in 2022
October 17, 2022DNA Script made the list! Put together by Otta, the list features 100 startups, based on company employee growth rate, …
▶
▶
MEDIA COVERAGE
2022 Fierce Life Sciences Innovation Awards Finalists
October 15, 2022All of the entries were judged on the ability of the applicant to demonstrate the following: effectiveness, technical innovation, competitive …
▶
▶
